Importance of antimicrobial stewardship to the english national health service

Infection and Drug Resistance

Volumn 7, Issue , 2014, Pages 145-152

  Dixon, Jill ^a   Duncan, Christopher J A ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Antibiotics; Antimicrobial resistance; Clostridium difficile; Methicillin resistant staphylococcus aureus; National health service; Prescribing

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL STEWARDSHIP; DIAGNOSTIC PROCEDURE; DRUG USE; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; MICROORGANISM DETECTION; NATIONAL HEALTH SERVICE; NONHUMAN; PRACTICE GUIDELINE; PRESCRIPTION; PUBLIC HEALTH; REVIEW;

EID: 84901932348     PISSN: 11786973     EISSN: None     Source Type: Journal    
DOI: 10.2147/IDR.S39185     Document Type: Review

References (56)

1. Guyer B, Freedman MA, Strobino DM, Sondik EJ. Annual summary of vital statistics: trends in the health of Americans during the 20th century. Pediatrics. 2000;106:1307-1317.
2. Spellberg B Dr. William H. Stewart: mistaken or maligned? Clin Infect Dis. 2008;47:294.
3. Pier GB. On the greatly exaggerated reports of the death of infectious diseases. Clin Infect Dis. 2008;47:1113-1114.
4. Fauci AS, Morens DM. The perpetual challenge of infectious diseases. N Engl J Med. 2012;366:454-461.
5. Annual Report of the Chief Medical Officer 2011. Volume 2. Available from: https://www.gov.uk/government/publications/chief-medical-officer-annual-report-volume-2. Accessed February 20, 2014.
6. Smith R, Coast J. The true cost of antimicrobial resistance. BMJ. 2013;346:f1493.
7. Kessel AS, Sharland M. The new UK antimicrobial resistance strategy and action plan. BMJ. 2013;346:f1601.
8. Carlet J, Collignon P, Goldmann D, et al. Society's failure to protect a precious resource: antibiotics. Lancet. 2011;378:369-371.
9. Molstad S, Erntell M, Hanberger H, et al. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis. 2008;8:125-132.
10. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-177.
11. Barbut F, Jones G, Eckert C. Epidemiology and control of Clostridium difficile infections in healthcare settings: an update. Curr Opin Infect Dis. 2011;24:370-376.
12. O'Brien DJ, Gould IM. Maximizing the impact of antimicrobial stewardship: the role of diagnostics, national and international efforts. Curr Opin Infect Dis. 2013;26:352-358.
13. Davies SC, Fowler T, Watson J, Livermore DM, Walker D. Annual Report of the Chief Medical Officer: infection and the rise of antimicrobial resistance. Lancet. 2013;381:1606-1609.
14. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2096.
15. Bolan GA, Sparling PF, Wasserheit JN. The emerging threat of untreatable gonococcal infection. N Engl J Med. 2012;366:485-487.
16. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1-12.
17. Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13:785-796.
18. Ashiru-Oredope D, Sharland M, Charani E, McNulty C, Cooke J. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart - Then Focus. J Antimicrob Chemother. 2012;67 Suppl 1:i51-i63.
19. Nemeth J, Ledergerber B, Preiswerk B, et al. Multidrug-resistant bacteria in travellers hospitalized abroad: prevalence, characteristics, and influence on clinical outcome. J Hosp Infect. 2012;82:254-259.
20. Paltansing S, Vlot JA, Kraakman ME, et al. Extended-spectrum beta-lactamase-producing Enterobacteriaceae among travelers from The Netherlands. Emerg Infect Dis. 2013;19:1206-1213.
21. Wickramasinghe NH, Xu L, Eustace A, Shabir S, Saluja T, Hawkey PM. High community faecal carriage rates of CTX-M ESBL-producing Escherichia coli in a specific population group in Birmingham, UK. J Antimicrob Chemother. 2012;67:1108-1113.
22. Nathwani D, Sneddon J, Patton A, Malcolm W. Antimicrobial stewardship in Scotland: impact of a national programme. Antimicrob Resist Infect Control. 2012;1:7.
23. Department of Health, Department for Environment, Food and Rural Affairs. UK Five Year Antimicrobial Resistance Strategy 2013-2018. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/244058/20130902_UK_5_year_AMRstrategy.pdf. Accessed February 20, 2014.
24. United States National Library of Medicine and National Institutes of Health. The path of least resistance. 1998. Available from: http://www.advisorybodies.doh.gov.uk/smac1.htm. Accessed February 20, 2014.
25. Department of Health. UK antimicrobial resistance strategy and action plan. 2000. Available from: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4007783. Accessed February 20, 2014.
26. Department of Health. The Health and Social Care Act 2008: Code of Practice for health and adult social care on the prevention and control of infections and related guidance. 2008. Available from: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_110288. Accessed February 20, 2014.
27. McNulty CA. European Antibiotic Awareness Day 2012: general practitioners encouraged to TARGET antibiotics through guidance, education and tools. J Antimicrob Chemother. 2012;67:2543-2546.
28. Cooke J, Alexander K, Charani E, et al. Antimicrobial stewardship: an evidence-based, antimicrobial self-assessment toolkit (ASAT) for acute hospitals. J Antimicrob Chemother. 2010;65:2669-2673.
29. Ashiru-Oredope D, Hopkins S. Antimicrobial stewardship: English Surveillance Programme for Antimicrobial Utilization and Resistance (ESPAUR). J Antimicrob Chemother. 2013;68:2421-2423.
30. Pulcini C, Williams F, Molinari N, Davey P, Nathwani D. Junior doctors' knowledge and perceptions of antibiotic resistance and prescribing: a survey in France and Scotland. Clin Microbiol Infect. 2011;17:80-87.
31. Minen MT, Duquaine D, Marx MA, Weiss D. A survey of knowledge, attitudes, and beliefs of medical students concerning antimicrobial use and resistance. Microb Drug Resist. 2010;16:285-289.
32. van der Velden LB, Tromp M, Bleeker-Rovers CP, et al. Non-adherence to antimicrobial treatment guidelines results in more broad-spectrum but not more appropriate therapy. Eur J Clin Microbiol Infect Dis. 2012;31:1561-1568.
33. National Prescribing Centre. A single competency framework for all prescribers. Available from: http://www.npc.nhs.uk/improving_safety/improving_quality/. Accessed Accessed February 20, 2014.
34. Department of Health and Public Health England. Antimicrobial prescribing and stewardship competencies. Available from: https://www.gov.uk/government/publications/antimicrobial-prescribing-and-stewardship-competencies. Accessed February 20, 2014.
35. Cals JW, Boumans D, Lardinois RJ, et al. Public beliefs on antibiotics and respiratory tract infections: an Internet-based questionnaire study. Br J Gen Pract. 2007;57:942-947.
36. Akkerman AE, Kuyvenhoven MM, van der Wouden JC, Verheij TJ. Determinants of antibiotic overprescribing in respiratory tract infections in general practice. J Antimicrob Chemother. 2005;56:930-936.
37. Akkerman AE, Kuyvenhoven MM, van der Wouden JC, Verheij TJ. Analysis of under- and overprescribing of antibiotics in acute otitis media in general practice. J Antimicrob Chemother. 2005;56:569-574.
38. Stockley JM. European Antibiotic Awareness Day 2012: getting smart about antibiotics, a public-professional partnership. J Infect. 2012;65: 377-379.
39. McNulty CA, Nichols T, Boyle PJ, Woodhead M, Davey P. The English antibiotic awareness campaigns: did they change the public's knowledge of and attitudes to antibiotic use? J Antimicrob Chemother. 2010;65: 1526-1233.
40. Francis NA, Butler CC, Hood K, Simpson S, Wood F, Nuttall J. Effect of using an interactive booklet about childhood respiratory tract infections in primary care consultations on reconsulting and antibiotic prescribing: a cluster randomised controlled trial. BMJ. 2009;339:b2885.
41. Moore M. Antibiotics: time to act. Br J Gen Pract. 2013;63:340-341.
42. Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev. 2005;4:CD003539.
43. Gjelstad S, Hoye S, Straand J, Brekke M, Dalen I, Lindbaek M. Improving antibiotic prescribing in acute respiratory tract infections: cluster randomised trial from Norwegian general practice (prescription peer academic detailing (Rx-PAD) study). BMJ. 2013;347:f4403.
44. Gerber JS, Prasad PA, Fiks AG, et al. Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians: a randomized trial. JAMA. 2013;309:2345-2352.
45. Davey P, Brown E, Charani E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4:CD003543.
46. Gaieski DF, Mikkelsen ME, Band RA, et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med. 2010;38:1045-1053.
47. Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA. 2009;302:1059-1066.
48. Albrich WC, Dusemund F, Bucher B, et al. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL). Arch Intern Med. 2012;172:715-722.
49. Liew YX, Lee W, Cai YY, et al. Utility and safety of procalcitonin in an antimicrobial stewardship program (ASP) in patients with malignancies. Eur J Clin Microbiol Infect Dis. 2012;31:3041-3046.
50. Hohn A, Schroeder S, Gehrt A, et al. Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock. BMC Infect Dis. 2013;13:158.
51. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13:426-435.
52. Saeed K, Dryden M, Bourne S, Paget C, Proud A. Reduction in antibiotic use through procalcitonin testing in patients in the medical admission unit or intensive care unit with suspicion of infection. J Hosp Infect. 2011;78:289-292.
53. Sauer S, Kliem M. Mass spectrometry tools for the classification and identification of bacteria. Nat Rev Microbiol. 2010;8:74-82.
54. Perez KK, Olsen RJ, Musick WL, et al. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med. 2013;137:1247-1254.
55. Geiger K, Brown J. Rapid testing for methicillin-resistant Staphylococcus aureus: implications for antimicrobial stewardship. Am J Health Syst Pharm. 2013;70:335-342.
56. Fricke WF, Rasko DA. Bacterial genome sequencing in the clinic: bioinformatic challenges and solutions. Nat Rev Genet. 2014;15(1): 49-55.